IC50: 0.29-0.52 μM (H+/K+-ATPase)[1].
[1]. Takahashi N, et al. Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility. J Pharmacol Exp Ther. 2018 Feb;364(2):275-286.
陕西缔都医药化工有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
缔都医药